Clinical Trial: A Randomized, Controlled, Open-Label, Multicenter Clinical Trial Comparing Anti-HER2 Therapy Combined with Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB–II Gastric Cancer with High HER2 Expression (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Controlled, Open-Label, Multicenter Clinical Trial Comparing Anti-HER2 Therapy Combined with Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB–II Gastric Cancer with High HER2 Expression'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132821

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Air Force Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338987

Published by HT Digital Content Services with permission from Health Dail...